Literature DB >> 21085982

Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease.

Petra Bago Rožanković1, Arijana Lovrenčić Huzjan, Hrvoje Cupić, Ines Jajić Benčić, Silvio Bašić, Vida Demarin.   

Abstract

Citotoxin-associated gene-A (CagA)-positive Helicobacter pylori strains have been associated with occurrence and destabilization of coronary atherosclerotic plaques. However, data on the relationship between CagA-positive H. pylori infection and carotid artery instability are lacking. Thus, the role of CagA antigen in patients with symptomatic and asymptomatic carotid atherosclerotic plaques was investigated. A total of 64 patients with advanced carotid artery stenosis, including 33 patients with symptomatic and 31 patients with asymptomatic internal carotid artery stenosis, verified by duplex ultrasound, all undergoing carotid endarterectomy, were studied. The control group consisted of 65 subjects without a history or presence of vascular diseases. Serology for H. pylori and CagA antigen was assessed in all participants. Specimens of atherosclerotic plaques obtained from all patients during carotid endarterectomy were analyzed immunohistochemically using anti-CagA monoclonal antibodies. The ultrasonographic plaque characteristics were also estimated. CagA antibody titers were significantly higher in symptomatic patients (8.8; range, 5.8-32.7) compared to asymptomatic patients (4.7; range, 2.1-8.8; P = 0.005) and the control group (5.0; range 2.2-7.9; P < 0.001). There was significant difference in echolucency (≥ 25% soft material) between the symptomatic and asymptomatic groups (P = 0.034) by ultrasonographic evaluation. Positive immunoreactivity between monoclonal CagA antibodies and antigens within atherosclerotic specimens was significantly higher among symptomatic patients compared to asymptomatic patients (97.0 vs. 74.2%; P = 0.009). H. pylori may play a role in the pathogenesis of the atherosclerotic process due to autoimmune mechanisms and even contribute to destabilization of carotid atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085982     DOI: 10.1007/s00415-010-5824-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

1.  Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization.

Authors:  S Jander; M Sitzer; R Schumann; M Schroeter; M Siebler; H Steinmetz; G Stoll
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

2.  Evidence of a chronic systemic cause of instability of atherosclerotic plaques.

Authors:  P M Rothwell; R Villagra; R Gibson; R C Donders; C P Warlow
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

3.  Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis.

Authors:  Mark Fisher; Annlia Paganini-Hill; Aldana Martin; Michele Cosgrove; James F Toole; Henry J M Barnett; John Norris
Journal:  Stroke       Date:  2005-01-13       Impact factor: 7.914

4.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

5.  Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis.

Authors:  Vincenzo Pasceri; Giuseppe Patti; Giovanni Cammarota; Christian Pristipino; Giuseppe Richichi; Germano Di Sciascio
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

6.  Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques.

Authors:  Marisa Benagiano; Mario M D'Elios; Amedeo Amedei; Annalisa Azzurri; Ruurd van der Zee; Alessandra Ciervo; Gianni Rombolà; Sergio Romagnani; Antonio Cassone; Gianfranco Del Prete
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis.

Authors:  Jianhui Zhu; Richard J Katz; Arshed A Quyyumi; Daniel A Canos; David Rott; Gyorgy Csako; Alexandra Zalles-Ganley; Jibike Ogunmakinwa; Alan G Wasserman; Stephen E Epstein
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

8.  The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis.

Authors:  Filippo Cremonini; Maurizio Gabrielli; Giovanni Gasbarrini; Paolo Pola; Antonio Gasbarrini
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

9.  Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease.

Authors:  Tomoyuki Okada; Kiyoshi Ayada; Shinichi Usui; Kenji Yokota; Jinhua Cui; Yoshiro Kawahara; Tomoki Inaba; Satoshi Hirohata; Motowo Mizuno; Daisuke Yamamoto; Shozo Kusachi; Eiji Matsuura; Keiji Oguma
Journal:  J Autoimmun       Date:  2007-07-02       Impact factor: 7.094

10.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  15 in total

Review 1.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

Review 2.  Progress in cerebrovascular disease research in the last year.

Authors:  Sergio Amaro; Angel Chamorro
Journal:  J Neurol       Date:  2012-01-19       Impact factor: 4.849

Review 3.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

4.  Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation.

Authors:  Agnieszka Matusiak; Maciej Chałubiński; Marlena Broncel; Tomasz Rechciński; Karolina Rudnicka; Eliza Miszczyk; Maria Walencka; Dominik Strapagiel; Adrian Gajewski; Magdalena Chmiela
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

Review 5.  Molecular mimicry in Helicobacter pylori infections.

Authors:  Magdalena Chmiela; Weronika Gonciarz
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

6.  Association of helicobacter pylori infection with severity of coronary heart disease.

Authors:  Mehran Rogha; Davood Dadkhah; Zahra Pourmoghaddas; Keivan Shirneshan; Marjan Nikvarz; Masoud Pourmoghaddas
Journal:  ARYA Atheroscler       Date:  2012

7.  Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor?

Authors:  Jamshid Vafaeimanesh; Seyyed Fakhroldin Hejazi; Vahid Damanpak; Mostafa Vahedian; Mohammadamin Sattari; Mohammadreza Seyyedmajidi
Journal:  ScientificWorldJournal       Date:  2014-01-16

8.  Gastric autoantigenic proteins in Helicobacter pylori infection.

Authors:  Ji Sook Park; Su-Jin Lee; Tae Hyo Kim; Jeongsuk Yeom; Eun-Sil Park; Ji-Hyun Seo; Jin-Su Jun; Jae-Young Lim; Chan-Hoo Park; Hyang-Ok Woo; Hee-Shang Youn; Gyung-Hyuck Ko; Hyung-Lyun Kang; Seung-Chul Baik; Woo-Kon Lee; Myung-Je Cho; Kwang-Ho Rhee
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

9.  Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.

Authors:  Asako Shimoda; Koji Ueda; Shin Nishiumi; Naoko Murata-Kamiya; Sada-Atsu Mukai; Shin-ichi Sawada; Takeshi Azuma; Masanori Hatakeyama; Kazunari Akiyoshi
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

10.  Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome-Mediated Mechanism.

Authors:  Xiujuan Xia; Linfang Zhang; Jingshu Chi; Huan Li; Xiaoming Liu; Tingzi Hu; Rong Li; Yinjie Guo; Xue Zhang; Hui Wang; Jin Cai; Yixi Li; Da Liu; Yuqi Cui; Xilong Zheng; Gregory C Flaker; Duanfang Liao; Hong Hao; Zhenguo Liu; Canxia Xu
Journal:  J Am Heart Assoc       Date:  2020-03-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.